# How should patent prosecutors manage AI-related prosecution risk in 2026?

patentreviewpro.com · August 28, 2026

> What Counts as AI Prosecution Risk in 2026 Patent prosecution risk in the AI space in 2026 is not a single category. It spans at least four distinct...

## What Counts as AI Prosecution Risk in 2026

Patent prosecution risk in the AI space in 2026 is not a single category. It spans at least four distinct exposure types that practitioners have to triage separately: (1) subject matter eligibility under Section 101, where courts and the USPTO continue to apply the two-step Alice/Mayo framework to machine learning claims; (2) prior art risk created by rapid preprint, open-source, and conference disclosure cycles in AI; (3) enablement and written description risk under Section 112(a), particularly for claims that recite neural network architectures without sufficient structural or functional detail; and (4) a newer and rapidly expanding category — disclosure risk arising from the use of generative AI tools by inventors and attorneys during the drafting and prosecution process. The National Law Review has reported that disclosure of confidential invention material into publicly available generative AI tools can be treated as a public disclosure, potentially triggering one-year on-sale and statutory bar timelines under 35 U.S.C. § 102(b). Treating these four buckets as a single "AI risk" is a common and costly mistake; each one has different mitigation protocols.

**Also worth reading:** [How are generative AI patent drafting tools used safely and effectively in patent prosecution?](https://patentreviewpro.com/knowledge/how_are_generative_ai_patent_drafting_tools_used_safely_and_effectively_in_patent_prosecution.php) · [What are the most effective AI patent prosecution strategies for 2026?](https://patentreviewpro.com/knowledge/what_are_the_most_effective_ai_patent_prosecution_strategies_for_2026.php) · [How much does AI patent prosecution cost analysis actually save law firms and applicants in 2026?](https://patentreviewpro.com/knowledge/how_much_does_ai_patent_prosecution_cost_analysis_actually_save_law_firms_and_applicants_in_2026.php)

A second framing problem is treating AI prosecution risk as purely technical. The IPWatchdog practitioner commentary published in the 2026 Q2 cycle characterizes patent risk as a portfolio-level discipline: where to file, in which jurisdictions, under which claim formats, and with which continuation strategy. AI complicates every one of those decisions because the underlying technology changes faster than examination backlogs can absorb. PatentReviewPro treats AI prosecution risk management as a workflow problem, not a doctrine problem, because the doctrine is already largely settled — what changes is execution speed, disclosure hygiene, and the choice between in-house and outside prosecution resources.

## The 2026 Disclosure Hygiene Problem

The single highest-impact change in 2026 is the recognition that pasting invention material into a public generative AI tool can constitute public disclosure. The National Law Review's 2026 coverage describes how attorneys and inventors using ChatGPT, Claude, Gemini, and similar services may be inadvertently publishing the invention before the priority date. Even where the receiving model is not training on inputs, the act of transmission to a third-party hosted service can be characterized as a "publication" or "on-sale" event depending on jurisdiction. This is a non-obvious shift: most engineering teams have been told that AI tools are private by default, and the legal reality is more complicated.

The practical consequence is that prosecution hygiene now requires a documented "AI use policy" for every matter. The policy should specify which tools are approved, what data classes may be entered, whether the tool is enterprise-licensed with a contractual no-retention clause, and how the policy is enforced at the inventor level. The U.S. Patent and Trademark Office has not (as of August 2026) issued a binding rule on the topic, but the policy direction in the 2026 Federal Register activity, combined with the National Law Review reporting, suggests that practitioners should expect guidance or rulemaking within the next 12 to 18 months. Inventors and outside counsel should not wait for that rule before acting, because the one-year clock can start without warning.

The second-order effect is on inventor interviews and inventor declarations. If an inventor used a public AI tool to refine a claim limitation, that fact may need to be disclosed in the prosecution file. Failure to disclose it can create inequitable conduct exposure, which is a separate and severe risk. Sterne Kessler's 2026 collaboration with Thomson Reuters, announced in March 2026, formalized a workflow that bakes in disclosure hygiene at the drafting stage rather than treating it as a post-hoc audit.

## Section 101 Eligibility: What Actually Works in 2026

Subject matter eligibility remains the most heavily litigated gate. In 2026, the USPTO's 2024 Revised Patent Subject Matter Eligibility Guidance continues to be the operative examination framework, and the Federal Circuit has issued several decisions refining how abstract idea analysis applies to AI claims. Claims that recite a generic computing implementation of a mathematical operation — for example, "training a neural network on labeled data to classify X" without further technical detail — are still being rejected at a high rate. Claims that tie the AI to a specific technical improvement in a specific system (lower latency, reduced memory footprint, specific hardware acceleration, concrete sensor configuration) are still being allowed.

The IAM Patent 2026 Q2 Special Report on the US Patent Strategy Reset documents that applicants are responding to this environment by filing more continuation applications, more divisionals, and by structuring claim sets around the technical improvement rubric rather than around the algorithm itself. Drafting around eligibility is now table-stakes for AI prosecution; the question is no longer whether to do it, but how many claim sets to file and which technical improvement to emphasize. Practitioners report that claim sets that pair a system claim with a method claim and a non-transitory computer-readable medium claim have a noticeably higher allowance rate than single-format filings in the AI space.

There is also an emerging 2026-specific strategy of using continuation practice to preserve eligibility options. If the first-filed claim set is rejected as abstract, a continuation can present a more technical-improvement-focused version while preserving the original priority date. This is a real tool, but it carries cost. Each continuation adds filing fees, attorney time, and prosecution cycle delay, so the strategy is not free and should be applied selectively.

## Prior Art in an AI World: Velocity and Coverage

The prior art landscape for AI inventions has changed dramatically since 2022. Preprint servers (arXiv, bioRxiv, OpenReview), open-source repositories (GitHub, Hugging Face, PyTorch Hub), conference proceedings (NeurIPS, ICML, ACL, CVPR), and corporate research blogs now publish AI-relevant disclosures on a cycle measured in weeks, not years. The traditional examiner search has not kept pace. Several 2026 surveys of patent prosecution outcomes show that examiner-cited prior art in AI matters has shifted away from patents and toward non-patent literature, which has implications for how applicants should structure their own IDS (Information Disclosure Statement) submissions.

The Foley & Lardner 2026 analysis of AI in life sciences observes that patent analysis is increasingly shaping AI-driven target and drug candidate selection, which means the AI invention itself is often the prior art search tool. This creates an interesting circularity: a tool used to search prior art may itself generate or surface prior art that becomes relevant. Practitioners should treat prior art searching in AI matters as a continuous process rather than a one-time pre-filing exercise, and the IDS should be updated as prosecution proceeds. Under 37 C.F.R. § 1.56, applicants and attorneys have a duty to disclose material prior art they are aware of, and the threshold of "materiality" in 2026 has been interpreted broadly by the courts.

A practical and underused tactic is for the applicant to file an early and comprehensive IDS that covers non-patent literature proactively. While there is no statutory reward for over-disclosure, there is a real downside to under-disclosure. The Federal Circuit's 2022 decision in In re: Miovision tightened the inequitable conduct standard, but the underlying duty remains broad, and an inventor who has been reading arXiv preprints but not disclosing them creates exposure that a careful IDS policy would eliminate.

## Section 112 Risk: The Specificity Trap

Section 112(a) requires that the specification describe the invention in sufficient detail to satisfy enablement and written description. AI claims that recite a neural network architecture in functional terms without disclosing structure, training data characteristics, hyperparameter ranges, or example implementations are at elevated risk. The Federal Circuit has not been sympathetic to functional claiming at the level of "a neural network trained to perform X" without more. The 2026 case law trend continues to require at least one concrete instantiation in the specification that puts the PHOSITA (person having ordinary skill in the art) in possession of the invention.

The Lilly 2026 situation, reported in the Wall Street Journal on March 30, 2026, illustrates the operational pressure on AI prosecution: as clients internalize more AI-related patent work in-house (as Eli Lilly has reportedly done with portions of its portfolio), the question of how much technical detail to put in the specification becomes a resource allocation question, not just a legal one. In-house teams that draft narrower specifications to save time may find themselves with patents that are easier to obtain but harder to enforce. The trade-off is real and should be made explicitly, not by accident.

Drafters should consider including at least one worked example, at least one set of hyperparameter ranges or architectural diagrams, and at least one concrete performance metric in the specification. None of these is strictly required for allowance, but each one reduces the surface area for an enablement attack during litigation.

## Tooling and Workflow: What Has Actually Shipped in 2026

The 2026 procurement landscape for AI-assisted patent prosecution tools is maturing. Fish & Richardson's FishStream AI, announced via Business Wire in 2026, is one of the higher-profile proprietary tools from a law firm. Sterne Kessler's partnership with Thomson Reuters (announced March 2026) targets the prior art and drafting workflow. Reuters has separately published evaluations of generative AI tools for patent drafting that should be required reading for any procurement team — the conclusion is that 2026-era tools are good at boilerplate and prior art summarization, but unreliable at the legal reasoning that turns a draft into a prosecuted patent.

The table below summarizes the practical trade-offs of the major 2026 tool categories.

| Tool Category | Primary Use | Strength in 2026 | Known Limitation | Approx. Cost Range |
| --- | --- | --- | --- | --- |
| Enterprise LLMs (Claude, GPT, Gemini enterprise tiers) | Drafting boilerplate, IDS summaries, office action shell responses | Speed on first drafts; good with template input | Hallucinates case citations and claim language; cannot be trusted unsupervised | $20–$60/user/month enterprise |
| Proprietary firm tools (e.g., FishStream AI) | End-to-end prosecution workflow | Integrated with firm data; covers drafting, IDS, and response generation | Only available through the firm; not portable to in-house teams | Built into firm fees |
| Patent-specific AI (e.g., Sterne Kessler/Thomson Reuters, IPRally, PatentPal) | Prior art search, claim charting, figure drafting | Strong on prior art and claim charts; better citation hygiene than general LLMs | Still require attorney review; no autonomous filing | $5,000–$50,000/year per seat |
| Open-source + internal RAG stacks | Custom workflows for large in-house teams | Full control over data; auditable | Requires ML engineering and IP expertise on staff | $200k+ to build, plus ongoing engineering |
| Traditional patent search (PatSnap, Orbit, Derwent) | Manual prior art and freedom-to-operate | Mature, predictable, well-understood | Not AI-native; slow for AI-related disclosures | $10,000–$100,000/year |

The 2026 consensus among practitioners is hybrid: traditional search for foundational prior art, patent-specific AI for first-pass coverage, and human review for everything that touches legal conclusions. Tools that promise fully autonomous prosecution should be treated with skepticism — the National Law Review's 2026 coverage of generative AI disclosure risk makes clear that the attorney of record remains responsible for the content of every filed paper.

## Practical Steps for a 2026 Risk-Management Program

A workable program in August 2026 looks like this. First, the firm or in-house team should adopt a written AI use policy within 30 days. The policy should cover which tools are approved, what data classes may be entered, and what the disclosure consequences are. Second, the team should inventory every active AI-related matter and tag each one for Section 101, Section 112, prior art, and disclosure-hygiene risk. Third, the team should standardize the IDS process to include non-patent literature as a default. Fourth, the team should require attorney review of every AI-generated claim draft, office action response, and declaration — this is not optional under current rules and probably will not be optional under 2027 rules. Fifth, the team should budget for at least one continuation in AI matters where Section 101 rejection is anticipated, and price the continuation into the original filing decision.

A common and expensive mistake is to treat these five steps as a one-time setup. The AI legal landscape is changing fast enough that the program should be reviewed at least quarterly, and the policy should be revised whenever a new tool is added, a new jurisdiction becomes relevant, or a relevant Federal Circuit decision issues. The IAM Patent 2026 Q2 Special Report describes the current period as a "reset" precisely because the rules of the previous decade do not map cleanly onto AI prosecution.

## When to Act and What to Watch For

The honest answer to "when should a patent team act on AI prosecution risk" is now, in 2026, because the one-year statutory bar under 35 U.S.C. § 102(b) does not wait for rulemaking. Specifically, if an inventor has entered invention material into a public AI tool in the past 12 months and the application has not yet been filed, the priority date calculation should be reviewed by counsel immediately. If the application has already been filed but the disclosure has not been documented in the file wrapper, the team should consider whether supplemental disclosure is required.

Over the next 12 to 24 months, practitioners should watch for four developments: (1) USPTO rulemaking or guidance on AI-assisted prosecution and AI inventorship; (2) Federal Circuit decisions further refining Section 101 application to AI claims; (3) PTAB (Patent Trial and Appeal Board) decisions on AI claim construction and obviousness; and (4) state or federal legislation on AI disclosure obligations. The 2026 Q2 reporting cycle suggests that the first two are the most likely to land in the next 12 months, and both will materially change how AI patent applications are drafted and prosecuted. PatentReviewPro recommends that practitioners build the policy framework now rather than waiting for the rule, because retroactive compliance is significantly more expensive than proactive compliance.

## Quick answers

### Does using ChatGPT to draft a patent application count as a public disclosure?

Under current 2026 U.S. law, transmission of invention material to a public generative AI service may be characterized as a publication or on-sale event, which can start the one-year clock under 35 U.S.C. § 102(b). Enterprise-licensed tools with contractual no-retention and no-training clauses are treated differently, but the analysis is fact-specific and should be reviewed by counsel for each matter.

### What is the biggest Section 101 risk for AI patent claims in 2026?

Claims that recite a generic computing implementation of a mathematical operation, such as a neural network performing classification, without a specific technical improvement tied to a concrete system, continue to face a high rejection rate. The 2026 strategy is to anchor claims in technical improvement, sensor/hardware specifics, or measurable performance gains, and to file parallel claim sets across system, method, and computer-readable medium formats.

### How often should an AI-related IDS be updated during prosecution?

Given the rapid publication cycle in AI (preprints, open-source releases, conference papers), the IDS should be treated as a continuous process rather than a one-time filing. Practitioners should review arXiv, major AI conferences, and key open-source repositories for new disclosures at least every 60 to 90 days during active prosecution and supplement the IDS when material prior art is identified.

### Are AI patent prosecution tools reliable enough to file unsupervised in 2026?

No. 2026-era tools are reliable for boilerplate generation, prior art summarization, and first-draft drafting, but they hallucinate case citations and claim language with enough frequency that unsupervised filing creates significant professional responsibility and inequitable conduct exposure. Attorney review of every filed paper remains mandatory.

### How much does a continuation strategy add to AI patent prosecution cost?

Filing a single continuation in 2026 typically adds $2,000 to $5,000 in USPTO fees for a large entity, plus 15 to 40 hours of attorney and paralegal time, depending on claim set complexity. For AI matters where Section 101 rejection is anticipated, budgeting one continuation into the original filing decision is now considered standard practice, and the trade-off between filing cost and eligibility fallback should be made explicitly.

Canonical: https://patentreviewpro.com/knowledge/how_should_patent_prosecutors_manage_ai-related_prosecution_risk_in_2026.php
Markdown: https://patentreviewpro.com/knowledge/how_should_patent_prosecutors_manage_ai-related_prosecution_risk_in_2026.php/index.md